Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Abstract The development of cancer vaccines is based on the premise that tumor cells are potentially targetable by host immunity through the effective presentation of tumor‐associated antigens to reactive T‐cell populations. Vaccine efficacy may be limited by the functional properties of effector ce...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2021-06-01
|
| Saila: | ImmunoMedicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/imed.1021 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|